Product Reports Resources Pricing Login Book a demo

PMV Pharmaceuticals

Biotech & Life Sciences · Cranbury Township, United States · Founded 2013 · IPO 2020

PMV Pharmaceuticals, Inc. is a pioneering biotechnology company focused on developing innovative treatments for cancer. The company specializes in creating first-in-class p53 regulators, targeting the most commonly mutated protein in human cancers. By harnessing over three decades of p53 biology, PMV Pharma combines a unique biological understanding with a strong focus on pharmaceutical development. PMV Pharma operates in the biotechnology and pharmaceutical market, primarily serving patients suffering from various forms of cancer. The company's business model revolves around the research, development, and commercialization of novel cancer therapies. Revenue is generated through the successful development and eventual sale or licensing of their proprietary treatments. The company is led by a team of industry and academic thought leaders who are dedicated to discovering new treatments for human diseases. This leadership team brings together extensive experience in both scientific research and pharmaceutical development, ensuring a robust approach to tackling cancer. PMV Pharma's core mission is to harness the power of p53 to treat cancer, offering hope and potential cures to millions of patients worldwide. The company is headquartered in Cranbury, NJ, and continues to make significant strides in the field of oncology. Keywords: p53 regulators, cancer treatment, biotechnology, pharmaceutical development, oncology, novel therapies, scientific research, cancer patients, innovative treatments, academic leaders.

Total funding $100–500M
Power Law Unicorn$1–10B valuation tier

Investors

11 investors on PMV Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
OrbiMed
InterWest Partners
Osage University Partners
Series B+ 8 investors entered at this stage
Nextech Invest
Viking Global Investors
Euclidean Capital
Boxer Capital
RA Capital Management
Avoro Capital Advisors
Wellington Management
Denali Advisors

Global footprint

Where PMV Pharmaceuticals has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States95.7%
🇦🇺 Australia2.1%
🇨🇭 Switzerland2.1%
3 countries shown
Web traffic by country
6.6K monthly visits
across markets
🇺🇸 United States68.2%
🇯🇵 Japan25.8%
🇨🇦 Canada3%
🇮🇳 India3%
Top 4 markets shown

Talent graph

The shape of PMV Pharmaceuticals's talent

Dealroom maps PMV Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 team members profilednamed & role-tagged by Dealroom
68 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock PMV Pharmaceuticals's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$22M patent portfolio · 20 active families

Estimated portfolio value
$22M
3.8× smaller than top peer Ascentage Pharma ($83M)
20 active patent families
Where PMV Pharmaceuticals innovates Cancer researchCarcinosisDNAEffectorMutant

Where PMV Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across PMV Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about PMV Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about PMV Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PMV Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles